Arlington, VACIK 9448044 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
107 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Jpmorgan Chase & Co. | 560.7K | $180.68M | 4.8% | −116.7K | Reduced |
| 2 | Goldman Sachs Group Inc | 167.7K | $147.39M | 3.9% | −22.9K | Reduced |
| 3 | Alphabet Inc | 430.9K | $135.21M | 3.6% | +137.5K | Added |
| 4 | Parker-Hannifin Corp |
| 143.5K |
| $126.15M |
| 3.3% |
| −19.9K |
| Reduced |
| 5 | Lam Research Corp | 717.0K | $122.74M | 3.3% | −356.8K | Reduced |
| 6 | Abbvie Inc | 530.7K | $121.26M | 3.2% | −125.6K | Reduced |
| 7 | Meta Platforms Inc | 159.5K | $105.29M | 2.8% | −22.0K | Reduced |
| 8 | Citigroup Inc | 873.3K | $101.90M | 2.7% | −117.8K | Reduced |
| 9 | Microsoft Corp | 204.7K | $98.99M | 2.6% | −28.3K | Reduced |
| 10 | Abbott Labs | 786.2K | $98.50M | 2.6% | −107.0K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio